Natalie Dakers

Board Member

Natalie Dakers has been in the business of commercializing leading-edge technology for over 30 years. Over her career she has been the founding CEO of several companies and organizations including a biopharmaceutical pain company, the national translational science centre and its commercialization arm, and a unique pre-seed investment accelerator. She is known as builder who gets things done and has served as a mentor for the Creative Destruction Lab, LifeSciences BC and SFU VentureLabs working with early-stage companies. She is currently the CEO of A2O Advanced Materials Inc., a spinoff from the University of British Columbia, that is transforming adhesion in high impact industries to make products last longer with reduced waste. Ms. Dakers currently serves on the Boards of Augurex Life Sciences Corp, LifeLabs, Sonic Incytes, and STEMCELL Technologies.